Clinical Trial Update: Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating genistein supplementation to mitigate cardiometabolic dysfunction in patients undergoing androgen deprivation therapy for prostate canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Genistein (genistein)

Snippet

Sponsor: Emory University | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-09-27